Harbin Pharmaceutical Group Co Ltd
SSE:600664
Wall Street
Price Targets
Price Targets Summary
Harbin Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Harbin Pharmaceutical Group Co Ltd
is 4.71 CNY
with a low forecast of 4.67 CNY and a high forecast of 4.85 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Harbin Pharmaceutical Group Co Ltd's stock price target?
Price Target
4.71
CNY
According to Wall Street analysts, the average 1-year price target for
Harbin Pharmaceutical Group Co Ltd
is 4.71 CNY
with a low forecast of 4.67 CNY and a high forecast of 4.85 CNY.
What is Harbin Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Harbin Pharmaceutical Group Co Ltd's revenue is
-1%.
The projected
CAGR
for the next 3 years is
10%.
What is Harbin Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Harbin Pharmaceutical Group Co Ltd's operating income is
-1%.
The projected
CAGR
for the next 3 years is
16%.
What is Harbin Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Harbin Pharmaceutical Group Co Ltd's net income is
-3%.
The projected
CAGR
for the next 3 years is
11%.
